Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi Zhi Wei Tong granules
- Development stage
- Phase 4
- Lead developer
- China Resources Sanjiu Medical & Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qi Zhi Wei Tong granules (also known as Qi-Zhi-Wei-Tong Keli) is a traditional Chinese patent medicine approved by the National Medical Products Administration (NMPA) of China for the treatment of functional dyspepsia and gastrointestinal motility and sensory disorders. It is a multi-herb formulation composed of six traditional Chinese medicinal herbs: Radix Bupleuri (Chaihu), Rhizoma Corydalis (Yanhusuo), Fructus Aurantii (Zhike), Rhizoma Cyperi (Xiangfu), Radix Paeoniae Alba (Baishao), and Radix Glycyrrhizae (Gancao). Qi Zhi Wei Tong granules work by soothing the liver, regulating Qi, and relieving stomach pain. Preclinical and clinical studies suggest that the formulation alleviates visceral hypersensitivity, improves gastric motility, reduces low-grade duodenal inflammation, and strengthens the mucosal barrier, potentially by modulating gut microbiota and bile acid metabolism.
- Brand names
- 999 Qi Zhi Wei Tong KeliQi Zhi Wei Tong Keli
- Other names
- Qi-Zhi-Wei-Tong KeliQi-Zhi-Wei-Tong granulesQZWTQZWTGQizhi Weitong KeliQizhi Weitong granules
02
Targets
DRD2 (Dopamine D2 Receptor)mAChR (Muscarinic acetylcholine receptors)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Qi Zhi Wei Tong granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qi Zhi Wei Tong granules.